Balance Sheet

Current Liabilities	295.7m
Accounts Payable	42.8m
Accrued Liabilities	180.1m
Other Current Liabilities	72.8m
Non-Current Liabilities	309.2m
Long-Term Debt	33.1m
Other Non-Current Liabilities	276.1m

Currency: AUD

	Jun-2017	Jun-2018	Jun-2019	Jun-2020	Jun-2021	Jun-2022	Jun-2023
Assets
Cash & Cash Equivalents	63	87	89	138	98	97	93
Cash	63	87	89	138	98	97	93
Short-Term Investments	0	0	0	0	0	0	128
Total Receivables	234	275	257	233	191	282	210
Accounts Receivables	224	252	251	192	173	259	177
Other Receivables	10	23	6	41	18	23	32
Inventory	106	82	100	94	103	109	83
Other Current Assets	19	36	25	26	25	24	41
Total Current Assets	422	481	472	491	417	512	554
PP&E Net	189	230	236	238	222	226	51
PP&E Gross	189	230	236	238	222	226	51
Accumulated Depreciation	31	42	62	89	102	127	57
Intangible Assets	1 177	1 034	776	940	616	405	617
Goodwill	58	21	22	22	20	22	0
Note Receivable	0	0	0	0	13	0	0
Other Long-Term Assets	61	65	130	134	176	123	25
Other Assets	58	21	22	22	20	22	0
Total Assets	1 908 N/A	1 831 -4%	1 636 -11%	1 825 +12%	1 463 -20%	1 288 -12%	1 247 -3%
Liabilities
Accounts Payable	67	64	50	30	42	64	32
Accrued Liabilities	73	79	68	70	64	113	196
Short-Term Debt	0	0	37	41	42	63	11
Current Portion of Long-Term Debt	13	0	14	4	12	345	4
Other Current Liabilities	41	38	42	74	62	45	69
Total Current Liabilities	193	181	211	219	223	629	311
Long-Term Debt	327	374	319	353	293	6	33
Deferred Income Tax	57	34	31	29	13	6	8
Minority Interest	9	9	6	5	3	8	0
Other Liabilities	19	6	61	181	163	109	261
Total Liabilities	604 N/A	604 0%	629 +4%	788 +25%	695 -12%	742 +7%	613 -17%
Equity
Common Stock	1 130	1 132	1 140	1 239	1 239	1 239	1 234
Retained Earnings	161	41	232	318	519	795	717
Other Equity	12	54	100	117	49	102	118
Total Equity	1 304 N/A	1 226 -6%	1 007 -18%	1 038 +3%	768 -26%	546 -29%	634 +16%
Total Liabilities & Equity	1 908 N/A	1 831 -4%	1 636 -11%	1 825 +12%	1 463 -20%	1 288 -12%	1 247 -3%
Shares Outstanding
Common Shares Outstanding	76	78	79	84	88	88	83

Mayne Pharma Group Ltd
ASX:MYX